Bloomberg News

Celesio Plans to Sell DocMorris Pharmacy Business, FAZ Reports

March 26, 2012

Celesio AG (CLS1) plans to sell its DocMorris mail-order pharmacy business, Frankfurter Allgemeine Zeitung reported, without saying where it got the information.

Celesio has hired Deutsche Bank AG (DBK) to seek potential buyers, FAZ reported in an e-mailed preview of a story to be published tomorrow. The sale is scheduled to be completed this year, and the unit may bring a price of more than 100 million euros ($133.2 million), the newspaper reported.

Rainer Berghausen, a Celesio spokesman, declined to comment by telephone today.

To contact the reporter on this story: Naomi Kresge in Berlin at nkresge@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus